Ngozi Erondu
Publications by Year
Research Areas
Pharmacology and Obesity Treatment, Psoriasis: Treatment and Pathogenesis, Diabetes Treatment and Management, Tuberculosis Research and Epidemiology, Regulation of Appetite and Obesity
Most-Cited Works
- → Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes(2017)7,624 cited
- → Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis(2015)792 cited
- → Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials(2018)634 cited
- → Biochemical and immunochemical evidence that the "major postsynaptic density protein" is a subunit of a calmodulin-dependent protein kinase.(1983)614 cited
- → Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events(2017)500 cited
- → Purification and characterization of a calmodulin-dependent protein kinase that is highly concentrated in brain.(1983)490 cited
- → Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis(2014)390 cited
- → Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program(2015)321 cited
- → Why do obese patients not lose more weight when treated with low-calorie diets? A mechanistic perspective(2007)227 cited
- → The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake(2008)200 cited